Current and historical daily PE Ratio for BMRN (
Biomarin Pharmaceutical Inc
) from 1999 to May 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biomarin Pharmaceutical stock (BMRN) PE ratio as of May 11 2024 is 75.73.
More Details
Biomarin Pharmaceutical Inc (BMRN) PE Ratio (TTM) Chart
Biomarin Pharmaceutical Inc (BMRN) PE Ratio (TTM) Historical Data
View and export this data going back to 1999. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Biomarin Pharmaceutical PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-05-11 | 75.7 | 2024-03-08 | 97.7 |
2024-05-10 | 75.7 | 2024-03-07 | 97.6 |
2024-05-09 | 76.4 | 2024-03-06 | 98.6 |
2024-05-08 | 76.5 | 2024-03-05 | 97.8 |
2024-05-07 | 77.2 | 2024-03-04 | 99.7 |
2024-05-06 | 76.7 | 2024-03-01 | 99.0 |
2024-05-03 | 77.0 | 2024-02-29 | 98.0 |
2024-05-02 | 78.3 | 2024-02-28 | 100.5 |
2024-05-01 | 77.9 | 2024-02-27 | 103.0 |
2024-04-30 | 75.5 | 2024-02-26 | 102.4 |
2024-04-29 | 76.8 | 2024-02-23 | 103.7 |
2024-04-26 | 75.6 | 2024-02-22 | 102.2 |
2024-04-25 | 76.8 | 2024-02-21 | 100.6 |
2024-04-24 | 85.2 | 2024-02-20 | 100.8 |
2024-04-23 | 86.0 | 2024-02-16 | 100.9 |
2024-04-22 | 83.6 | 2024-02-15 | 100.3 |
2024-04-19 | 82.8 | 2024-02-14 | 97.7 |
2024-04-18 | 84.2 | 2024-02-13 | 97.9 |
2024-04-17 | 84.5 | 2024-02-12 | 100.2 |
2024-04-16 | 84.9 | 2024-02-09 | 100.5 |
2024-04-15 | 85.5 | 2024-02-08 | 100.2 |
2024-04-12 | 86.2 | 2024-02-07 | 101.9 |
2024-04-11 | 85.5 | 2024-02-06 | 102.0 |
2024-04-10 | 84.3 | 2024-02-05 | 99.7 |
2024-04-09 | 83.2 | 2024-02-02 | 100.1 |
2024-04-08 | 81.6 | 2024-02-01 | 100.8 |
2024-04-05 | 81.3 | 2024-01-31 | 100.1 |
2024-04-04 | 81.2 | 2024-01-30 | 101.8 |
2024-04-03 | 81.1 | 2024-01-29 | 104.3 |
2024-04-02 | 81.1 | 2024-01-26 | 103.3 |
2024-04-01 | 81.4 | 2024-01-25 | 103.7 |
2024-03-28 | 81.6 | 2024-01-24 | 104.9 |
2024-03-27 | 100.7 | 2024-01-23 | 105.7 |
2024-03-26 | 99.7 | 2024-01-22 | 106.9 |
2024-03-25 | 98.3 | 2024-01-19 | 104.8 |
2024-03-22 | 96.7 | 2024-01-18 | 105.2 |
2024-03-21 | 95.6 | 2024-01-17 | 106.2 |
2024-03-20 | 96.3 | 2024-01-16 | 106.2 |
2024-03-19 | 96.9 | 2024-01-12 | 106.1 |
2024-03-18 | 95.2 | 2024-01-11 | 109.1 |
2024-03-15 | 95.3 | 2024-01-10 | 109.0 |
2024-03-14 | 95.9 | 2024-01-09 | 109.2 |
2024-03-13 | 96.3 | 2024-01-08 | 112.5 |
2024-03-12 | 96.8 | 2024-01-05 | 109.6 |
2024-03-11 | 97.7 | 2024-01-04 | 111.1 |
Biomarin Pharmaceutical Inc (BMRN) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Biomarin Pharmaceutical Inc
NAICS : 325412
SIC : 2834
ISIN : US09061G1013
Description